A groundbreaking implantable device for severe mechanical low back pain is delivering life-changing results for the first patient treated ...

A massive stride has been made in the pain medication industry. The U.S. Food and Drug Administration (FDA) announced Thursday its approval of a non-opioid treatment for moderate to severe acute pain ...

BROOMFIELD, Colo. - Aclarion, Inc. (NASDAQ: ACON, ACONW), a healthcare technology company with a market capitalization of $0.26 million, has announced its participation in the Selby Spine Conference, ...

FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain ...

Dr. Sigurd Berven to Highlight NOCISCAN Capabilities, Combining MR Spectroscopy and Augmented Intelligence (AI) NOCISCAN as New Gold Standard in Identifying a Source of Discogenic Pain BROOMFIELD, ...

Chronic low back pain can disrupt your daily life, keeping you from enjoying family moments, outdoor adventures or even simple tasks like walking or sitting comfortably. If traditional treatments ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new sophistication. The management of chronic pain in general is now being broadly ...

Abbott announced new four-year data showing the long-term and sustained relief that its proprietary BurstDR™ spinal cord stimulation (SCS) technology provides people with chronic pain, particularly ...

Elite sports stars, footballers and people living with chronic pain are just some of the clients of a Yorkshire myofascial release therapist. But what is myofascial release therapy? And why do they ...

Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...